[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"image-body\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:image-body":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":30,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100455789","phase-4-investigational-mri-clinical-software-and-hardware-100455789",false,"NCT05215132","Investigational MRI Clinical Software and Hardware","Study Evaluation of Feasibility and Reproducibility of Investigational MRI Clinical Software","Avery HS","Inclusion Criteria:\n\n* • At least 18 years of age\n\n  * Able to complete the MR safety questionnaire.\n  * Able to comprehend and provide informed consent in English.\n  * When contrast is being administered: healthy volunteers with a GFR≥60 ml\u002Fmin\n  * When contrast is being administered: patients with a GFR ≥30 ml\u002Fmin\n\nExclusion Criteria:\n\n* • When contrast is being administered: subjects with a GFR \\\u003C 30 ml\u002Fmin\n\n  * When contrast is being administered: subjects with acute kidney injury\n  * When contrast is administered, allergy to gadolinium-containing contrast media\n  * Contraindication to MRI (implanted device, claustrophobia, dyspnea precluding the ability to follow breath-hold instructions)\n  * Adults unable to consent\n  * Individuals who are not yet adults\n  * Pregnant or breastfeeding women\n  * Prisoners",true,"ALL","18 Years","90 Years",{"count":22,"type":23},2000,"ESTIMATED","INTERVENTIONAL",[26],"PHASE4","Patients and healthy volunteers will be scanned in order to test new sequences.",[29],"Image, Body",[31],"MRI hardware testing","RECRUITING","2026-04-21",{"date":35,"type":36},"2026-04-24","ACTUAL",{"date":38,"type":36},"2019-12-19",{"date":40,"type":23},"2028-01-31",{"name":42,"class":43},"Northwestern University","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":18,"minAge":4,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":44},"100400137","carbon-monoxide-intoxication-in-korea-prospective-cohort-care-co-cohort-100400137","NCT04490317","CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)","Inclusion Criteria:\n\n* Acute CO poisoning\n\nExclusion Criteria:\n\n* Declined to enrollment in the study",{"count":52,"type":23},1500,"OBSERVATIONAL","This prospective cohort study enrolls subjects who experience carbon monoxide (CO) poisoning. The purpose of the study is to evaluate therapeutic effects of various treatments and short and long-term outcomes in CO poisoned patients. In addition, complications of brain and heart susceptible to CO are investigated through various ways and the association between complications and the patient's prognosis is also investigated. All subjects will be regularly monitored by physicians participating in this study.",[56,57,58,29,59,60,61],"Carbon Monoxide Poisoning","Myocardial Injury","Neurologic Deficits","Therapy","Prognostic Factors","Complications","2024-07-22",{"date":64,"type":36},"2024-07-23",{"date":66,"type":36},"2020-07-29",{"date":68,"type":23},"2035-12",{"name":70,"class":43},"Wonju Severance Christian Hospital"]